| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Pain Management > Treatment of a Compound Fractures; Reflex Sympathetic Dystrophy/Chronic Regional Pain Syndrome pt.2 |
|
E-Articles - Treatment of a Compound Fractures; Reflex Sympathetic Dystrophy/Chronic Regional Pain Syndrome pt.2
This is my continuing story about my experience of the treatment of a compound fractures. Af According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ter finally landing I realized that at least I had not broken my neck, my greatest fear. My sister ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in and brother-in-law ran to find me at the bottom of the stairs. I had yelled out when first I reali lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ed that I was falling. My legs still positioned upwards, my face, part of my chest and hands the on here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ly things touching the floor at the bottom. I picked up my head from the floor. Blood flowed from d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y mouth telling all and me that I had apparently bitten my lip as my face hit my final destination. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Kind of funny how we almost hope to see blood so we can say, "See! I am too hurt!" It took awhile easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to finally decide that I could move forward. I crawled into the kitchen. My brother-in-law helped nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically me to a chair. It looked as if I may have broken my ankle but most assuredly had broken my wrist, m and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y right wrist. The bones pushed up against the skin. This was not something a band aid would cover ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi I would need treatment of a compound fractures. I have to tell you here that I am not a doc ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tor person. I just don't go very much. It was clear to me though that this was going to cause me t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod o seek one out. My sister took me to an emergency care clinic. After ex-rays I was relieved to kno cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin that I had not broken my ankle as well. "You are going to need an operation. We will schedule one tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen for you later today. You should go to the hospital now and check in." the staff at the emergency c t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel inic told me. "What?" All I could think of quite honestly was the cost. I, like so many Americans ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust have no health insurance. My sister did not have home owners. My plight became daunting at that po y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products int as I sifted through thoughts of helplessness. "How much will this cost?" my sister inquired. I . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de could only sit there and cry. "Well, it could cost anywhere up to eighteen, ummm, twenty one thous elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip and dollars." the aid replied. I was in pain yes, but I was also distraught. --------------------- tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Home Equity Loans - Benefits of A Home Equity Loan German Memories- Otto von Bismarck and the Unification of German States into a German Confederation The Secret to Developing Superior Confidence With Women
|